Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03400345 · ClinicalTrials.gov registry record

Human Upper Extremity Allotransplantation: F/U Protocol

A clinical trial of Amputation, Traumatic and Wounds and Injury, sponsored by Johns Hopkins University.

Recruiting
Registry status
60
Enrollment target
1
Study location

NCT03400345 is a study of Amputation, Traumatic and Wounds and Injury that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 60 participants, above the 48-participant average among 11 other Amputation, Traumatic trials with a reported enrollment target (25% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03400345, a study of Amputation, Traumatic and Wounds and Injury, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.

Study Locations (1)

Maryland

  • Johns Hopkins University School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-07-25
Est. Completion 2036-07-30

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03400345

The ClinicalTrials.gov registry entry for NCT03400345 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 48-participant average among 11 other Amputation, Traumatic trials with a reported enrollment target (25% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Amputation, Traumatic appearing as the primary indexed condition, and to 0 interventions.

NCT03400345 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03400345 about?

NCT03400345 is a clinical study titled "Human Upper Extremity Allotransplantation: F/U Protocol". Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient ...

What is the current status of trial NCT03400345?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2017-07-25. Estimated completion is 2036-07-30.

What conditions does trial NCT03400345 study?

This clinical trial studies the following conditions: Amputation, Traumatic, Wounds and Injury, Hand Injuries.

Who is sponsoring clinical trial NCT03400345?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03400345 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation, Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.